| |
|
|
 |
|
MEMPHIS,
Tenn.--(BUSINESS WIRE)--arGentis Pharmaceuticals, LLC announced
an agreement with The University of Tennessee Research Foundation
to license the intellectual property surrounding the use of
solubilized type 1 native bovine collagen (CI) as a treatment
for systemic sclerosis (SSc or systemic scleroderma) and other
fibrosing diseases. The agreement gives arGentis the rights
to the treatment as well as the processes involved in manufacturing
the pharmaceutical product. |
|
|
Jerusalem,
Israel - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)
announced that the U.S. Food and Drug Administration has granted
tentative approval for the Company's Abbreviated New Drug
Application (ANDA) for Sildenafil Citrate Tablets, 20 mg.
Final approval of this product is anticipated upon expiration
of patent protection for the brand product in March 2012. |
|
|
Many
of the speakers from the National Conference have shared their
handouts with us. Additional ones are expected, and we will
post them as we receive them. |
|
|
2007
APF Pain and Creativity Exhibit
The
pain and creativity community will be ongoing, but to be considered
for this opportunity to be honored and have your work featured,
we need your submissions by September 20th.
|
|
Watch
David Gilliland Race!
Watch
David Gilliland and the No. 25 car participate in tomorrow's
NASCAR Busch Carfax 250 at the Michigan Speedway in Brooklyn,
Mich. tomorrow at 3 p.m. on ESPN 2. The Foundation is an associate
sponsor of the vehicle. |
|
|
